ReviewFrontiers in endocrinology2026
Bone formation niche dysfunction in osteoporosis: insights from single-cell and spatial transcriptomic studies.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone formation is spatially organized, yet the molecular architecture of the bone formation niche has only recently become accessible. Osteoporosis is a major skeletal disorder characterized by bone loss, microarchitectural deterioration, and increased fracture risk. Although antiresorptive and anabolic therapies are effective, a key conceptual gap remains: the cellular components of bone formation are increasingly well defined, but how these cells are spatially arranged and coordinated in health and disease is less understood. Recent advances in single-cell RNA sequencing and spatial transcriptomics now allow transcriptome-wide mapping of bone-forming microenvironments in intact human and mouse tissues. This review synthesizes emerging findings into a spatial framework for understanding bone formation and osteoporosis. We trace the conceptual lineage from the bone-remodeling compartment canopy hypothesis to its molecular refinement through recent single-cell and spatial atlases. We integrate evidence for mesenchymal stromal cell heterogeneity and spatial niche organization to propose a three-zone model of the bone formation niche, comprising a canopy or marrow-side stromal zone, a reversal or transition zone, and a bone-surface formation zone. We further propose "spatial de-zonation" as a hypothesis-generating framework for osteoporosis, referring to the potential erosion of spatial gradients that normally separate osteogenic, stromal, vascular, and adipogenic domains. Importantly, the available human spatial atlases were generated predominantly from osteoarthritic femoral heads and therefore provide reference maps rather than direct evidence of osteoporosis-specific niche disorganization. Finally, we consider niche-restorative therapeutic strategies that may move beyond targeting individual cell types toward restoring the architectural integrity of the bone formation niche.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.